2,4,6-triiodophenol has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camacho, M; Casanova, I; Céspedes, MV; Frade, P; León, J; Mangues, R; Molins, A; Nomdedeu, JF; Parreño, M; Pavón, MA; Vaqué, JP; Vila, L | 1 |
1 other study(ies) available for 2,4,6-triiodophenol and Leukemia
Article | Year |
---|---|
Novel triiodophenol derivatives induce caspase-independent mitochondrial cell death in leukemia cells inhibited by Myc.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Biphenyl Compounds; Caspases; Cell Cycle; Cell Membrane Permeability; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; HL-60 Cells; Humans; K562 Cells; Leukemia; Lipoxygenase Inhibitors; Mice; Mitochondria; NIH 3T3 Cells; Phenols; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species | 2006 |